This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Laura Walker, Ph.D
Director at Adimab, LLC.


Laura Walker is the director of Antibody Sciences at Adimab, LLC. She received her B.S. degree in Biochemistry from the University of Wisconsin-Madison and her Ph.D. in immunology from the Scripps Research institute. At Scripps, Laura’s work focused on the identification and characterization of broadly neutralizing antibodies to HIV in the laboratory of Dennis Burton. More recently, her group at Adimab has been at the forefront of generating broad and highly potent neutralizing antibodies to a variety of viral pathogens, including Ebola, RSV, and Zika virus, which have applications in passive therapy and rational vaccine design.

Agenda Sessions

  • Antibody Affinity Maturation and Developability Improvement for Lead Optimization

  • Biophysical Properties of Human B cell-derived Antibodies

    On Demand
  • Broadly Neutralizing Antibodies to Speed Pandemic Responses

    On Demand
  • Responding to the COVID-19 Pandemic with Antibodies, Small Molecule Drugs and Vaccines